T&L Co., Ltd. Stock

Equities

A340570

KR7340570001

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
66,000 KRW +6.11% Intraday chart for T&L Co., Ltd. +4.76% +65.00%
Sales 2024 * 140B 101M Sales 2025 * 171B 124M Capitalization 533B 385M
Net income 2024 * 36B 25.99M Net income 2025 * 45B 32.49M EV / Sales 2024 * 3.24 x
Net cash position 2024 * 78.8B 56.89M Net cash position 2025 * 110B 79.78M EV / Sales 2025 * 2.47 x
P/E ratio 2024 *
14.8 x
P/E ratio 2025 *
11.8 x
Employees 142
Yield 2024 *
1.06%
Yield 2025 *
1.33%
Free-Float 53.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day+6.11%
1 week+4.76%
1 month+9.27%
3 months+33.33%
6 months+53.67%
Current year+65.00%
More quotes
1 week
60 600.00
Extreme 60600
66 400.00
1 month
56 600.00
Extreme 56600
71 600.00
Current year
37 500.00
Extreme 37500
71 600.00
1 year
37 500.00
Extreme 37500
71 600.00
3 years
28 800.00
Extreme 28800
71 600.00
5 years
18 225.00
Extreme 18225
71 600.00
10 years
18 225.00
Extreme 18225
71 600.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 65 -
Chief Tech/Sci/R&D Officer 54 -
Director/Board Member 55 -
Members of the board TitleAgeSince
Director/Board Member 60 -
Chief Executive Officer 65 -
Director/Board Member 59 -
More insiders
Date Price Change Volume
24-05-31 66,000 +6.11% 313,376
24-05-30 62,200 +0.16% 102,631
24-05-29 62,100 -0.64% 122,617
24-05-28 62,500 +0.64% 156,476
24-05-27 62,100 -1.43% 215,443

End-of-day quote Korea S.E., May 30, 2024

More quotes
T&L Co Ltd is a Korea-based company engaged in the manufacture and sale of wound treatment materials. The Company's main products include wound treatment materials, orthopedic fixing materials, structural adhesives, and water repellents. The wound treatment materials include products such as hydrocolloids, foams, and hydrogels as wetting dressing agents necessary for wound healing. The orthopedic fixture materials include medical devices used for the treatment and correction of fractures such as casts and splints. The company sells its products in domestic and overseas markets such as the United States, Germany, China, and Dubai.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
66,000 KRW
Average target price
71,500 KRW
Spread / Average Target
+8.33%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. A340570 Stock